期刊文献+

结核分枝杆菌Rpf-DNA疫苗对Mtb感染小鼠免疫保护作用的研究

Rpf-DNA Vaccine for M. tuberculosis Infected Mice
下载PDF
导出
摘要 目的评价Mtb复苏因子DNA疫苗(resuscitation-promoting factor DNA, Rpf-DNA)对Mtb感染宿主的免疫保护作用。方法构建复苏因子D(Rpf D—DNA)和复苏因子E(Rpf E-DNA)质粒疫苗,180只BALB/c小鼠(4周龄)分为6组,每组30只,分别用空质粒、Rpf D-DNA质粒、Rpf E-DNA质粒、BCG、生理盐水免疫,H37Rv标准株气溶胶感染。检测血清复苏因子(Rpf)抗体、IFN—γ;Rpf D、E刺激淋巴细胞后进行淋巴细胞增殖、细胞杀伤实验;检测细胞上清IFN-γ、IL-12、IL-2;对肺组织进行病理学检测和细菌负荷(CFU)计数。结果(1)疫苗免疫组血清RpfD、RpfE抗体水平:RpfD组0.32±0.1,RpfE组0.39±0.1,BCG组0.02±0.01,空质粒组0.01±0.0,生理盐水组0.09±0.04,空白对照组0.03±0.01,RpfD组与RpfE组抗体水平与BCG组、空质粒组、生理盐水组、空白对照组比较差异有显著统计学意义,F值分别为RpfD:45.6,43.2,45.1,45.7;RpfE:51.6,53.6,51.0,52.2:P值均〈0.01。血清IFN-γ:RpfD组(43.9±24.8)pg/ml,RpfE组(45.9±21.0)pg/ml,BCG组(21.0±11.0)pg/ml,空质粒组(7.9±4.9)pg/ml,生理盐水组(4.7±2.1)pg/ml,空白对照组(5.8±4.7)pg/ml,RpfD、RpfE质粒组与BCG组比较差异有统计学意义(F值分别为RDfD:10.2;RpfE:12.4;P值均〈0.05),与空质粒组、生理盐水组、空白对照组比较差异有显著统计学意义,F值分别为RpfD:15.6,17.8,17.3;RpfE:17.5,21.1,20.7P值均(0.01。(2)淋巴细胞增殖实验CCK-8:RpfD组176.0±4.2,RpfE组183.0±4.3,BCG组101.0±1.1,空质粒组100.0±6.8,生理盐水组104.0±8.4,空白对照组116.0±2.2,RDfD、RpfE质粒组与BCG组、空质粒组、生理盐水组、空白对照组比较差异有统计学意义,F值分别为RpfD:9.5,10.1,10.0,9.0;RpfE:11.2,12.9,11.7,10.3;P值均〈0.05。细胞杀伤实验:RpfD组32.0±3.2,RpfE组30.0±4.2,BCG组16.0±5.9,空质粒组3.3±1.5,生理盐水组6.7±0.5,空白对照组7.3±3.5,RpfD、RpfE质粒组与BCG组、空质粒组、生理盐水组、空白对照组比较差异有统计学意义,F值分别为RpfD:8.8,14.5,13.7,11.9;RpfE:8.1,12.5,11.6,11.1;P值均〈0.05。(3)RpfD、RpfE蛋白各自刺激淋巴细胞后上清细胞因子检测:IL-2:RpfD组9.5±2.4,RpfE组9.2±1.2,BCG组2.4±2.1,空质粒组1.2±0.3,生理盐水组1.8±1.0,空白对照组1.5±0.7,RpfD、RpfE质粒组与其他各组比较差异有统计学意义,F值分别为RpfD:12.5,14.6,13.5,13.9;RpfE:12.0,13.6,13.1,13.2:P值均〈0.05。IFN—γ:RpfD组22.2±5.7,RpfE组28.7±14.4,BCG组16.1±10.1,空质粒组9.8±1.6,生理盐水组13.2±2.1,空白对照组15.7±2.9,RpfD、RDfE质粒组与其他各组比较差异有统计学意义,F值分别为RpfD:7.8,12.6,8.7,8.3;RpfE:11.3,16.4,14.7,14.2;P值均〈0.05。结论实验表明复苏因子疫苗能诱导Mtb感染小鼠产生体液免疫和细胞免疫,有希望成为结核病候选疫苗之一。 Objective To evaluate the immune protective effect of resuscitation promoting factor (Rpf) DNA vaccine on M.tuberculosis (Mtb) infected mice. Method Rpf D and Rpf E plasmid DNA vaccines were construct.180 BALB/c mice with 4weeks of age were divided into 6 groups, 30 mice each group were immunized with empty plasmid, Rpf D plasmid DNA, Rpf E plasmid DNA, BCG and saline,respectively.All of mice were infected by aerosol with Mtb H37Rv. Serum anti-Rpf D or E antibodies and IFN-γ were detected. The lymphocyte proliferation assay and cytotoxicity test were performed, IFN- γ, IL-12 and IL-2 levels were tested after immunization with RpfD, EDNA vaccine. Histopathologic examination of the lung and CFU count were performed. Results ( 1 ) The antibody levels against RpfD and E were as follow:Rpf D group 0.32±0.1, Rpf E group 0.39±0.1, BCG group 0.02±0.01, empty plasmid group 0.01±0.0, saline group 0.09±0.04, blank group 0.03±0.01.The antibody levels in RpfD group and E group were significantly higher than those in BCG group, empty plasmid group, saline group, and blank group (F value:Rpf D: (45.6, 43.2, 45.1, 45.7);RpfE: (51.6, 53.6, 51.0, 52.2);P〈0.01). Serum IFN-γ evels:Rpf D group (43.9±24.8) pg/ml, Rpf E group (45.9±21.0) pg/ml, BCG group (21.0±11.0) pg/ml, empty plasmid group (7.9±4.9) pg/ml, saline group (4.7±2.1) pg/ml, blank group (5.8±4.7) pg/ml, Serum IFN-γ levels of RpfD group and E group were higher than empty plasmid group, saline group, and blank group (F value:Rpf D:15.6, 17.8, 17.3 Serum IFN-γ levels of Rpf E:17.5, 21.1, 20.7, P〈0.01) . (2) The lymphocyte proliferation assay using cell counting kit-8 (CCK-8) showed:Rpf D group 176.0±4.2, Rpf E group 183.0±4.3, BCG group 101.0±1.1, empty plasmid group 100.0±6.8, saline group 104.0±8.4, blank group 116.0±2.2, which in vaccine groups were significantly higher than the other controls (F value:Rpf D:9.5, 10.1, 10.0, 9.0, Rpf E:11.2, 12.9, 11.7, 10.3, P〈0.05) . Cytotoxicity test showed:Rpf D group 32.0±3.2, Rpf E group 30.0±4.2, BCG group 16.0±5.9, empty plasmid group 3.3±1.5, saline group 6.7±0.5, blank group 7.3±3.5. The proliferation index in RpfD group and RpfE group was higher than the other control groups (F value Rpf D:8.8, 14.5, 13.7, 11.9; Rpf E:8.1, 12.5, 11.6, ll.1;P〈0.05) . (3) Cytokines in the supernatant of lymphocytes stimulated by Rpf D and Rpf E:IL-21evel:Rpf D group 9.5±-2.4, Rpf E group 9.2±1.2, BCG group 2.4±2.1, empty plasmid group 1.2±0.3, saline group 1.8 ± 1.0, blank group 1.5 ± 0.7. The IL-2 levels in RpfD group and RpfE group were higher than the other control groups (F value Rpf D: 12.5, 14.6, 13.5, 13.9 ; Rpf E:12.0, 13.6, 13.1, 13.2 ; P〈0.05) . IFN-γ level : Rpf D group 22.2±5.7, Rpf E group 28.7± 14.4, BCG group 16.1±10.1, empty plasmid group 9.8± 1.6, saline group 13.2±2.1, blank group 15.7±2.9. The IFN-γ level in RpfD group and RpfE group were higher than the other control groups (F value Rpf D:7.8, 12.6, 8.7, 8.3; Rpf E:11.3, 16.4, 14.7, 14.2 : P〈0.05) . Conclusion RpfD and RpfE DNA vaccines can induce immune responses including humoral and cellular immunogenicity in Mtb infected BALB/c mice. Rpf might be used as the vaccine candidate.
出处 《结核病与胸部肿瘤》 2012年第3期166-171,共6页 Tuberculosis and Thoracic Tumor
基金 基金项目:国家科技重大专项(2008ZX10003-001) 北京卫生人才培养计划(2009-3-51)
关键词 分枝杆菌 结核 细菌蛋白质类 细胞因子类 疫苗 DNA Mycobacterium tuberculosis Bacterial proteins Cytokines Vaccines, DNA
  • 相关文献

参考文献12

  • 1Yeremeev VV, Kondratieva TK, Rubakova El,et al. Proteins ofthe Rpf family:immune cell reactivity and vaccination efficacy againsttuberculosis in mice.Infect Immun. 2003,71(8): 4789-4794.
  • 2邢爱英,刘忠泉,贾红彦,李自慧,郑晓静,曹廷明,杜风娇,杜博平,古淑香,张宗德.复苏因子E-DNA疫苗对BALB/C小鼠免疫效应的研究[J].实用医学杂志,2010,26(23):4259-4261. 被引量:4
  • 3Gao H, Bai Y,Xue Y, et al.Expression, purification, andcharacterization of soluble RpfD with high bioactivity as a recombinantprotein in Mycobacterium vaccae.Protein Expr Purif, 2007, 55(1):112-118.
  • 4刘忠泉,邢爱英,贾红彦,李自慧,郑晓静,曹庭明,杜风娇,杜博平,古淑香,张宗德.结核分枝杆菌复苏因子E的真核表达及鉴定[J].国际呼吸杂志,2010,30(24):1490-1494. 被引量:2
  • 5Fan A,Jian W,Shi C,et al.Production and characterization ofmonoclonal antibody against Mycobacterium tuberculosis RpfB domain.Hybridoma(Larchmt), 2010, 29(4): 327-332.
  • 6OttenhoffTH, Overcoming the global crisis: “yes,we can”,but also forTB…. EurJ Immunol, 2009,39(8): 2014-2020.
  • 7Caccamo N, Guggino G,Joosten SA, et al. Multifunctional CD4(+)T cells correlate with active Mycobacterium tuberculosis infection. Eur JImmunol, 2010, 40(8):2211-2220.
  • 8Gupta RK, Srivastava BS, Srivastava R. Comparative expressionanalysis of rpf-like gene of Mycobacterium tuberculosis H37Rv underdifferent physiological stress and growth conditions.Microbiology,2010,155(Pt9): 2714-2722.
  • 9Bigger JW.Treatment of staphylococcal infections with penicillin byintermittent sterilisation.Lancet. 1944,244(6320): 497-500.
  • 10Kana BD, Mizrahi V. Resuscitation-promoting factors as lytic enzymesfor bacterial growth and signaling.FEMS Immunol Med Microbiol,2010,58(1): 39-50.

二级参考文献19

  • 1唐权,陈峻崧,窦骏.结核DNA疫苗免疫策略研究进展[J].微生物学免疫学进展,2005,33(2):79-82. 被引量:7
  • 2Andersen P.Vaccine strategies against latent tuberculosis infection[J].Trends Microbiol,2007,15(1):7-13.
  • 3Chan J,Kaufmann S.Immune mechanisms of protection[M] //Bloom B R.Tuberculosis:pathogenesis,protection and control.Washington,D.C:American Society of Microbiology,1994:389-415.
  • 4Mustafa A S.Development of new vaccines and diagnostic reagents against[J].Mol Immunol,2002,39(1-2):113-119.
  • 5Yeremeev V V,Kondratieva T K,Rubakova E I,et al.Proteins of the Rpf family:immune cell reactivity and vaccination efficacy against tuberculosis in mice[J].Infect Immun,2003,71(8):4789-4794.
  • 6Radaeva T V,Nikonewnko B V,Kapina M A,et al.Experimental approaches to designing vaccines against tuberculous infection reactivation[J].Probl Tuberk Bolezn Legk,2006(5):45-48.
  • 7Russell-Goldman E,Xu J,Wang X,et al.A mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes[J].Infecti Immun,2008,76(9):4269-4281.
  • 8Kumar H,Malhotra D,Goswami S,et al.How far have we reached in tuberculosis vaccine development?.Crit Rev Microbiol,2003,29:297-312.
  • 9Andersen P.Vaccine strategies against latent tuberculosis infection.Trends Microbiol,2007,15:7-13.
  • 10Kell DB,Young M.Bacterial dormancy and culturability:the role of autocrine growth factors.Curr Opin Microbiol,2000,3:238-243.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部